Ani Pharmaceuticals (ANIP) Shares Outstanding (2010 - 2026)

Ani Pharmaceuticals (ANIP) has 17 years of Shares Outstanding (Entity) data on file, last reported at $20.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 6.67% year-over-year to $20.9 million; the trailing twelve-month figure through Mar 2026 stood at $20.9 million (up 6.67% YoY), and the FY2025 full-year result was $23.1 million, up 7.31% from the prior year.
• Shares Outstanding (Entity) eased to $20.9 million in Q1 2026, from $23.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $23.1 million in Q4 2025 to a low of $16.1 million in Q1 2022.
• A 5-year average of $18.8 million and a median of $19.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 34.66% in 2022 and rose 1.58% in 2023, its largest moves.
• Tracing ANIP's Shares Outstanding (Entity) over 5 years: stood at $16.3 million in 2022, then climbed by 10.71% to $18.0 million in 2023, then climbed by 19.65% to $21.5 million in 2024, then grew by 7.31% to $23.1 million in 2025, then retreated by 9.51% to $20.9 million in 2026.
• Business Quant data shows ANIP's Shares Outstanding (Entity) at $20.9 million in Q1 2026, $23.1 million in Q4 2025, and $20.1 million in Q3 2025.